{"nct_id":"NCT01623115","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy","status":"COMPLETED","status_verified_date":"2016-01","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2014-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}